【レポートの概要（一部）】
1. Report Overview
1.1 Overview of the World Market for Sexual Dysfunctions Treatment
1.2 Why You Should Read This Report
1.3 How This Study Delivers
1.4 Main Questions Answered by this Analysis
1.5 Who is this Report For?
1.6 Methods of Research and Analysis
1.7 Frequently Asked Questions (FAQs)
1.8 Some Associated Reports
1.9 About Visiongain
2. Introduction to Sexual Dysfunctions and Treatment Options
2.1 Diagnosis – ICD-10 and DSM-V
2.2 Male Sexual Dysfunctions
2.2.1 Sexual Desire Dysfunctions
2.2.2 Erectile Dysfunction
2.2.3 Priapism
2.2.4 Peyronie’s Disease
2.2.5 Premature Ejaculation
2.2.6 Hypogonadism
2.3 Female Sexual Dysfunctions
2.3.1 Dysfunctions of Arousal
2.3.2 Persistent Sexual Arousal Syndrome
2.3.3 Dysfunctions of Orgasm
2.3.4 Sexual Pain Dysfunctions
2.3.4.1 Dyspareunia
2.3.4.2 Vaginismus
2.3.5 Vulvodynia
3. The World Sexual Dysfunctions Drugs Market, 2015-2026
3.1 Global Sexual Dysfunctions Drugs Forecast 2015-2026
3.2 Sexual Dysfunction Drugs Market by Drug Class
3.2.1 PDE5 Inhibitors – Still Hold the Biggest Market Share
3.2.2 Prostaglandins – Dominated by Alprostadils
3.2.3 Androgens – Will New Delivery Technology Drive This Submarket?
3.2.4 Gonadotrophins – New Products Launched Expected
3.2.5 Other Drug Classes Market – Will See Significant Growth
3.3 Sexual Dysfunctions Drugs Market by Gender
3.3.1 Male Sexual Dysfunctions Drugs Market 2015-2026 – Declining as Originator Drugs Lose Patent Protection
3.3.2 Female Sexual Dysfunctions Drugs Market 2015-2026 – a Developing Market Holding Promising Commercial Potential
4. Sexual Dysfunction-Treating Drugs: Revenue Forecasts, 2015-2026
4.1 Cialis (Eli Lilly) – Faces Patent Expiry
4.2 Viagra (Pfizer) – Will Extended Patent in the US Protect Revenue?
4.3 Gonal-F (Merck KGaA) – Slow Growth in the First Half of the Forecast Period
4.4 Puregon (Merck & Co.) – Expected to Decline Significantly
4.5 Decapeptyl SR (Ipsen Ltd) – Growing Until the End of the First Half of the Forecast Period
4.6 Caverject Dual Chamber (Pfizer) – Growing During the First Half of the Forecast Period
4.7 Levitra (Bayer) – Sales Eroded by Cheaper PDE5 Inhibitors?
4.8 Nebido (Bayer) – Intramuscular Formulation of Testosterone Undecanoate
4.9 Testim (Ferring Pharmaceuticals) – Differentiated by Consistent Transdermal Absorption
4.10 Priligy (J&J/A. Menarini Pharma UK SRL) – SSRI to Treat Premature Ejaculation
4.11 Stendra/Spedra (VIVUS/Endo/Auxilium Pharmaceuticals) – Newest PDE5 Inhibitor
4.12 MUSE (Meda Pharmaceuticals) – Suppository Prostaglandin
4.13 Viridal Duo/Edex (UCB Pharma/Auxilium Pharmaceuticals) – Growing Strongly in the First Half of the Forecast Period
4.14 Tostran (ProStrakan Pharmaceuticals) – Eroded by Generic Competition Since 2014
4.15 Vitaros (Takeda) – Topical Formulation of Alprostadil
4.16 Restandol Testocaps (Merck & Co.) – Testosterone Replacement
4.17 Sustanon 250 (Aspen Pharma Trading) – Preferred Testosterone Replacement in the UK
4.18 Bemfola (Finox Biotech UK & Ireland Ltd.) – Biosimilar
4.19 Menopur (Ferring Pharmaceuticals) – a Preparation of Gonadotrophins
4.20 Pregnyl (Merck & Co.) – to Treat Hypogonadism
4.21 Androcur (Bayer Plc) – to Treat Androgen-related Conditions
4.22 Gonapeptyl (Ferring Pharmaceuticals) – Depot Injection
4.23 Intrinsa (Procter & Gamble) – Testosterone Patch
5. Emerging Therapies for Sexual Disorders
5.1 Vitaros (Takeda) – Topical Cream to Treat Erectile Dysfunction
5.2 Addyi (Sprout/Valeant Pharmaceuticals) – First Approved Drug for Female Sexual Dysfunction
5.3 Xiapex (Auxilium Pharmaceuticals)- First Approved Drug for Peyronie’s Disease
6. Leading Companies in the Sexual Dysfunction Drugs Market
6.1 Eli Lilly – Leading With Cialis
6.2 Pfizer – Will It Overtake Eli Lilly in This Forecast Period?
6.3 Merck KGaA – Driven by Sales in Emerging Markets
6.4 Merck & Co. – Will It Soon Lose Its Share to Competitors?
6.5 Ipsen Ltd – Ongoing Clinical Trials for Decapeptyl May Drive Further Growth
6.6 Bayer – Orodispersible Form of Levitra Not Pushing Revenue?
7. Leading National Markets: Revenue Forecasts, 2015-2026
7.1. The US Sexual Dysfunctions Drugs Market, 2015-2026 – Leader of the Pack
7.2. The Japanese Sexual Dysfunctions Drugs Market, 2015-2026 – Still Driven by Viagra and Cialis Sales
7.3 EU5 Sexual Dysfunctions Drugs Market, 2015-2026 – Cost Containment Will Slow the Market
7.4 BRIC Sexual Dysfunctions Drugs Market, 2015-2026 – Driven by Growth in China and India
7.5 Other Regions’ Sexual Dysfunctions Drugs Market, 2015-2026 – Expected High Growth Rate
8. R&D Pipelines for Sexual Dysfunctions Treatment
8.1 R&D Pipeline Drugs for Male Sexual Dysfunctions – Still Dominated by ED
8.1.1 Tissue Genesis Cell Isolation System (Tissue Genesis, Inc.) – ED
8.1.2 Adipose-Derived Stem Cell Injection (Ageless Regenerative Institute) – ED
8.1.3 Selegiline (University of South Florida) – ED
8.1.4 VL#FIA3-30 (VasoLead) – ED
8.1.5 MED2002 (Futura Medical) – ED
8.1.6 MED2005 (Futura Medical Developments Ltd) – ED
8.1.7 Fispemifene (NexMed) – ED and Secondary Hypogonadism
8.1.8 Transdermal Androgel (Johns Hopkins University) – Priapism
8.1.9 Adipose Tissue Stem Cell Injection (Man Clinic for Andrology, Male Infertility and Sexual Dysfunction) – Peyronie’s Disease
8.1.10 AA4500 and ErecAid Esteem Manual Vacuum Therapy System (Endo Pharmaceuticals) – Peyronie’s Disease
8.1.11 H-22411(Allergan) – Peyronie’s Disease
8.1.12 AA4500 (Allergan) – Peyronie’s Disease
8.1.13 IX-01 (Ixchelsis Limited) – Premature Ejaculation
8.1.14 CDFR0812-15 (CTC Bio, Inc.) – Premature Ejaculation
8.2 R&D Pipeline Drugs for Female Sexual Dysfunctions – Emerging Therapies
8.2.1 Tribulus Terrestris – Female Hypoactive Sexual Desire Disorder
8.2.2 Bremelanotide (Palatin Technologies) – Female Hypoactive Sexual Desire Disorder
8.2.3 Lybridos (Emotional Brain NY Inc.) – Female Hypoactive Sexual Desire Disorder
8.2.4 Lorexys (S1 Biopharma) – Female Hypoactive Sexual Desire Disorder
8.2.5 SST-6007 (Strategic Science & Technologies, LLC) – Female Hypoactive Sexual Desire Disorder
8.2.6 TBS-2 (Acerus Pharmaceuticals Corporation) – Orgasmic Disorder
8.2.7 SST-6006 (Strategic Science & Technologies, LLC) – Female Sexual Dysfunction
8.2.8 Fluocinonide Cream (OHSU Knight Cancer Institute National Cancer Institute (NCI)) – Painful Sexual Intercourse
9. Qualitative Analysis of the Sexual Dysfunctions Drugs Market 2015-2026
9.1 SWOT Analysis of the Sexual Dysfunctions Drugs Market, 2015-2026
9.1.1 Strengths
9.1.2 Weaknesses
9.1.3 Opportunities
9.1.4 Threats
9.2 STEP Analysis of the Sexual Dysfunctions Drugs Market, 2015-2026
9.2.1 Social
9.2.2 Technological
9.2.3 Economic
9.2.4 Political
10. Research Interviews from Our Survey – 2015
10.1 Dr. Carl Spana and Mr. Stephen Wills, Palatin Technologies
10.1.1 Palatin Technologies, Inc.
10.1.2 Female Sexual Dysfunction Market – What Are the Challenges?
10.1.3 Industry Effort to Bridge the Gaps
10.1.4 Drivers and Restraints of the FSD Market
10.1.5 Bremelanotide – On-Demand Treatment for HSDD
10.1.6 Designing Clinical Trials to Assess Drugs for FSDs – Remains a Challenge?
10.1.7 Commercial Potential of Bremelanotide
10.2 James Barder, CEO, Futura Medical
10.2.1 Futura Medical
10.2.2 Will the ED Treatment Market Show Growth?
10.2.3 Unmet Needs of ED Treatment and Management
10.2.4 MED2002 for ED – Targeted Delivery
10.2.5 DermaSys – Improves Permeation of APIs through the Skin
10.2.6 DermaSys –Therapeutic Benefits to Other Therapeutic Areas?
10.2.7 MED2002 – Could Potentially Meet the Unmet Demand in ED
11. Conclusions
11.1 Male Sexual Dysfunction Drugs Market
11.2 Female Sexual Dysfunction Drugs Market
11.3 Leading National Markets
11.4 Drugs in the Pipeline
【レポート販売概要】
■ タイトル：男性/女性性機能障害治療薬の世界市場2016-2026■ 英文：Male and Female Sexual Dysfunctions: Drug Market Report and Forecasts 2016-2026
■ 発行日：2015年12月
■ 調査会社：visiongain
■ 商品コード：VGAIN5122114
■ 調査対象地域：グローバル
- 2014年市場分析：日本の肝炎診断Complete report $3,900. DataPack (test volumes, sales forecasts, supplier shares) $2,500.The report presents a detailed analysis of the Hepatitis diagnostics market in Japan. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. The report provides five-year test volume and sales forecasts for HAV NAT, HBV NAT, HBs Ag, HCV, Anti-HBc, Anti-HBs, An …
- Ironhorse Oil & Gas Inc.：石油・ガスの開発・生産動向及びコスト分析- Q3, 2013Ironhorse Oil & Gas Inc. Oil & Gas Exploration and Production Operations and Cost Analysis - Q3, 2013 Summary Ironhorse Oil & Gas Inc. Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential …
- 慢性腎臓病（CKD）治療薬の世界市場2015-2019According to WHO, CKD is not only common, treatable, and harmful but also a major contributing factor to the incidence and outcomes of at least three of the diseases that are targeted by WHO (hypertension, diabetes, and CVD). CKD is mainly defined as a reduced GFR, increased urinary albumin excretion, or both, and is growing public health issue. CKD is classified into five stages (stages 1-5) acco …
- 3Dプリント複合材料の世界市場2019-2023About this market The increasing adoption of additive manufacturing will trigger the market’s growth in the forthcoming years. 3D printed composites are increasingly being used as raw materials in additive manufacturing. Vendors are also using additive manufacturing for offering products catering in different end-user industries including aerospace, automotive, and medical devices manufacturing in …
- 世界エンターテインメント産業におけるアニメーション及びデザインソフトウェア市場動向（2012-2016）TechNavio's analysts forecast the Global Animation and Design Software market in the Entertainment industry to grow at a CAGR of 21.10 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing adoption of 3D animation software. The Global Animation and Design Software market in the Entertainment industry has also been witnessing the development …
- 世界の小型自動車用電子制御ブレーキング市場【2015年1月更新版】This latest just-auto report edition offers a global review of the OE electronic braking sector, its suppliers, top markets, technologies and market forecasts. This global market study offers: Automotive OE electronic braking market size estimates Latest technologies and trends Market share data tables Exclusive interviews with major companies Profiles of the major players including their strategi …
- B型肝炎およびC型肝炎検査の世界市場2016-2020About Hepatitis B and Hepatitis C Hepatitis B diagnostic tests include HBV serologic tests, molecular deoxyribonucleic acid (DNA) tests, histology tests, and laboratory tests. HBV serologic tests involve the measurement of antigens and antibodies. Hepatitis C diagnostic tests include anti-HCV serologic test, HCV recombinant immunoblot assay (RIBA) antibody test, and HCV molecular ribonucleic acid …
- 世界の兵士現代化市場：市場規模及びドライバーSummary This report provides readers with a comprehensive analysis of the Soldier Modernization market through 2015-2025, including highlights of the demand drivers and growth stimulators for Soldier Modernization. It also provides an insight on the spending pattern and modernization pattern in different regions around the world. Key Findings The global soldier modernization market is expected to …
- シリコーンフィルムの世界市場予測（～2023年）“The silicone film market is projected to grow at a CAGR of 6.5%, in terms of value, from 2018 to 2023.” The market size of silicone film is estimated to be USD 794 million in 2018 and is projected to reach USD 1,087 million by 2023, at a CAGR of 6.5% from 2018 to 2023. The growth of the market is attributed to the high growth of end-use industries consuming silicone film. Another factor driving t …
- レーザー・キャプチャ・マイクロダイセクション（LCM）の世界市場：製品（消耗品、装置、ソフトウェア）、システム、用途、需要先、地域別分析The global laser capture microdissection market is expected to USD 124.97 million by 2020 from USD 72.45 million in 2015, at a CAGR of 11.52% between 2015 and 2020. By product, the market includes instruments, consumables, and software and services. The consumables product segment is further classified into reagents and media, assay kits, and other consumables. Based on application, the market is …
- 世界の軍用固定翼航空機の市場動向2013-2023：市場規模及び成長要因The global military aircraft market is estimated to value US$66.2 billion in 2013. The market consists of six categories of aircraft: multi-role, transport, attack, reconnaissance and surveillance, bombers, and training. The value of the global military aircraft market is expected to increase at a CAGR of 2.54% during the forecast period, to reach US$85 billion by 2023.
- グローバル・瘢痕治療（Scar Treatment）市場動向（2014-2018）About Scar Treatment Scar treatment products are applied on a scar to treat, heal, and conceal the scar. Products such as gels, creams, oils, and sprays are available as OTC products or are prescribed to treat scars. They are an alternative to invasive surgical treatment, laser treatment, elastic wraps, and gel sheets. Scar treatment application products are easy to use and cost-effective in compa …
- リン酸エステルの世界市場予測（～2020）Phosphate Ester: The global phosphate ester market was valued at USD 736.4 Million in 2014 and is expected to grow at a CAGR of 6.9% from 2015 to 2020. The market will grow due to high demand for phosphate esters from the Asia-Pacific region and technological advancements in lubricants, surfactants, pesticides, fire retardants, hydraulic fluids, plasticizers, and paints & coatings application-base …
- 世界の消泡剤市場2015The Global Defoamers Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Defoamers industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Defoamers market analysis is provided for the international markets including development trends, competitive landscap …
- 低圧セラミックコンデンサの世界市場2017-2021About Low-voltage Ceramic Capacitors Low-voltage ceramic capacitors are the most extensively used type of capacitors in various applications such as electronics, automotive, home appliances, and computers and peripherals. The application of ceramic capacitors dates to the 1930s where they were used in valve or tube circuits. Currently, low-voltage ceramic capacitors account for 55.51% of the globa …
